Blog Greenlight Biosciences Blog November 9, 2020 –– Blog Breaking the Vaccine Production Bottleneck: How to make a Messenger RNA vaccine GreenLight Biosciences is working on a Messenger RNA vaccine. In this piece, the team explains why a Messenger RNA vaccine is so vital and how to make it. Read More Mark Singleton welcomed as lead for plant health innovation CNN: Critical component for Covid-19 vaccines is in short supply Washington Post: scarcity of biotech ingredients The Economist: Covid-19 vaccine resource difficulties Business Insider: GreenLight named as one of six biotechs VCs are watching Financial Times: If Covid vaccines stop working, how quickly can drugmakers respond? Business Journal: Boston firms developing Covid vaccines STAT Opinion: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines Financial Times: Get vaccine new variant ready Mail Online: Vaccine roll out issues Financial Times: Vaccine makers race to fix vaccine supply issues Five Question Friday: Archie Mathura Technology Review: What are the Pfizer covid-19 vaccine ingredients? Financial Times: Vaccine manufacturing delays leave UK with fewer vaccines than hoped Investors Business Daily: Vaccine manufacturing challenge #WFH Series: Elisha Fielding CNBC: The challenges of Covid-19 vaccine production for the masses BioSpace: Harnessing Nature for Faster mRNA Vaccine Manufacturing Wired: Manufacturing enough Covid-19 vaccine is a logistical nightmare #WFH Series: Evelien Van Ekert